Coherus Oncology
CHRS
CHRS
111 hedge funds and large institutions have $595M invested in Coherus Oncology in 2018 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 40 increasing their positions, 31 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
36% less call options, than puts
Call options by funds: $531K | Put options by funds: $833K
43% less capital invested
Capital invested by funds: $1.05B → $595M (-$455M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
111
Holding in Top 10
1
Calls
$531K
Puts
$833K
Top Buyers
| 1 | +$21.9M | |
| 2 | +$15.6M | |
| 3 | +$14M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$6.33M |
| 5 |
State Street
Boston,
Massachusetts
|
+$4.2M |
Top Sellers
| 1 | -$28.4M | |
| 2 | -$17M | |
| 3 | -$11.6M | |
| 4 |
Millennium Management
New York
|
-$8.52M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$5.83M |